Trending Now
Announcements Consumer

Mayfair Legal Funding Offers Financial Support to Plaintiffs in Hernia Mesh Litigation

By Harry Moran |

As hernia mesh lawsuits continue to progress against major medical device manufacturers, Mayfair Legal Funding is stepping forward with financial solutions to support plaintiffs awaiting settlements. As a trusted provider of pre-settlement funding, Mayfair is committed to helping victims of defective hernia mesh implants manage their financial needs while pursuing justice.

Hernia Mesh Lawsuits and Manufacturer Liability

Hernia mesh implants, designed to provide long-term repair for hernias, have been linked to severe complications such as chronic pain, infections, adhesion, and organ perforation. Many affected individuals have filed lawsuits against manufacturers like C.R. Bard, Ethicon (a Johnson & Johnson subsidiary), and Medtronic, alleging that their mesh products were defectively designed and failed to provide the promised benefits.

The legal process for these cases is extensive, with thousands of plaintiffs waiting for settlements. A significant development occurred in October 2024 when C.R. Bard reached a settlement agreement involving approximately 38,000 lawsuits, though financial relief for many plaintiffs is still pending. As litigation continues, Mayfair Legal Funding is ensuring that victims are not forced into premature settlements due to financial strain.

Providing Relief During Lengthy Legal Proceedings

Hernia mesh complications can result in multiple surgeries, chronic pain, infections, and organ damage, significantly affecting victims’ quality of life. However, proving liability in court is a complex process that can extend for years. Manufacturers and their insurers frequently employ delaying tactics, making it difficult for plaintiffs to maintain financial stability while waiting for a fair settlement.

Many individuals who file lawsuits cannot work due to their medical conditions, yet they must continue paying for essential needs, ongoing healthcare, and legal costs. The prolonged nature of these lawsuits means that victims are often financially pressured to settle prematurely, even if their case could result in higher compensation with more time.

Why Legal Funding Matters

The pressure to settle early for a lower amount is common in hernia mesh litigation. Insurance companies and medical device manufacturers often attempt to delay proceedings, making it difficult for plaintiffs to maintain financial stability. Lawsuit loans allow plaintiffs to access a portion of their expected settlement upfront, helping cover urgent expenses such as medical treatments, rent, utilities, and other living costs. This financial support ensures that plaintiffs are not forced into disadvantageous settlements due to economic pressure.

Eligibility and Application Process

Plaintiffs who have filed a hernia mesh lawsuit and are represented by an attorney may be eligible for funding. Mayfair Legal Funding works closely with law firms handling hernia mesh cases to ensure that plaintiffs can access financial assistance without delays.

About Mayfair Legal Funding

Mayfair Legal Funding is a trusted provider of pre-settlement funding, helping plaintiffs in medical device lawsuits, including hernia mesh cases, stay financially stable while awaiting settlements. With a risk-free, non-recourse funding model, plaintiffs only repay if they win their case. Mayfair ensures fast approvals, access to funds within 24 hours, and no credit checks. To date, the company has provided $45 million in funding with a 94% approval rate.

About the author

Harry Moran

Harry Moran

Announcements

View All
Announcements Comercial People Moves

Victory Park Expands Legal Credit Leadership with Maleson Promotion

By John Freund |

Victory Park Capital (VPC), a global alternative asset manager specializing in private credit, has announced that Justin Maleson will expand his role to Managing Director, co-heading the firm’s legal credit investment strategy. The promotion underscores VPC’s ongoing investment in its legal finance capabilities and follows Maleson’s initial appointment in 2024 as Assistant General Counsel.

An announcement from Victory Park Capital details Maleson’s new responsibilities, which include sourcing, analyzing, and managing investments across legal assets, while maintaining oversight of the firm’s legal operations. He joins Chad Clamage in co-leading the strategy, working alongside team members Hugo Lestiboudois and Andrew Pascal, under the continued oversight of VPC CEO and founder Richard Levy.

Maleson brings a strong background in litigation finance and commercial law to the position. Before joining VPC, he served as a director at Longford Capital, where he specialized in originating and managing litigation funding transactions. His earlier tenure as a litigation partner at Jenner & Block further deepened his exposure to complex legal matters, equipping him with the expertise needed to navigate the nuanced legal credit space.

VPC’s legal credit team emphasizes an asset-backed lending model, prioritizing downside protection and predictable income streams. The firm aims to capitalize on inefficiencies within the legal funding market by leveraging its internal expertise and broad network of relationships. With Maleson’s appointment, VPC signals its intent to further scale its legal credit strategy, positioning itself as a key player in the evolving legal finance sector.

Maleson’s elevation comes at a time of increasing sophistication in litigation finance, where experienced legal minds are playing a pivotal role in portfolio construction and risk management. As VPC bolsters its leadership, the move may foreshadow further institutionalization of legal asset investing and heightened competition in a maturing market segment.

Announcements Consumer

Golden Pear Upsizes Corporate Note to $78.7M Amid Growth Plans

By John Freund |

Golden Pear Funding has extended and upsized its investment-grade corporate note to $78.7 million, further bolstering the firm's capacity to serve the expanding litigation finance sector. The New York-based funder, a national leader in both pre-settlement and medical receivables financing, said the proceeds will support working capital and fuel strategic growth initiatives.

A press release from Golden Pear outlines how the capital raise reflects continued investor confidence in the firm’s business model. CEO Gary Amos noted that the infusion is critical as Golden Pear seeks to scale alongside the “rapidly expanding litigation finance market.” CFO Daniel Amsellem added that the new funding aligns with the company’s capital allocation strategy, aimed at optimizing operational efficiency and executing strategic projects.

Brean Capital, LLC acted as the exclusive financial advisor and sole placement agent on the transaction.

Founded in 2008, Golden Pear has funded more than $1.1 billion to over 87,000 clients and remains one of the largest specialty finance companies in the U.S. Its business model spans legal case funding and medical receivables purchasing, with backing from a network of private equity partners that provide institutional support for continued expansion.

Announcements Regulatory Issues

LionFish Updates Model Documents in Response to CJC Report

By John Freund |

LionFish Litigation Finance Ltd has released a new suite of model litigation funding documents, updating its original set from February 2021. The revision comes on the heels of the Civil Justice Council's (CJC) Final Report on Litigation Funding, issued on 2 June 2025, which calls for a regulatory structure informed by best practices, including key principles published by the European Law Institute (ELI) in October 2024.

A LionFish press release details that the updated suite incorporates several of the ELI Principles (notably 4-12) and broader CJC recommendations, except where doing so would require legislative or procedural reform. LionFish's goal, according to Managing Director Tets Ishikawa, is not to dictate market norms but to foster industry-wide standardisation and efficiency. This proactive move is also intended to spark further collaboration between funders, insurers, and legal practitioners to develop trade practices akin to those in mature financial markets, such as those promoted by the Loan Market Association and the International Swaps and Derivatives Association.

The new suite includes three core documents: a litigation funding agreement, a priorities deed to define proceeds distribution, and an assignment deed for insurance benefits. Notably, LionFish has also added documentation for co-investment arrangements, reflecting a growing trend in syndicated funding deals. The funder has already closed seven such transactions.

Managing Director Tanya Lansky emphasised that while litigation funding remains complex, making documentation public enhances transparency and facilitates quicker deal closings—an essential factor for sustaining market growth.

As litigation finance continues to mature, this move by LionFish highlights a shift toward professionalisation and standardisation. With regulators increasingly focused on transparency and fairness, such initiatives may set a de facto benchmark for others in the industry. The question remains: will other funders follow suit, or will regulatory mandates be needed to compel alignment?